4 курс / Акушерство и гинекология / Кабатин_Н_А_Течение_беременности_и_перинатальные_исходы_при_различных
.pdf141
132.Nguyen C., Montz F.J., Bristow R.E. Management of stage I cervical cancer in pregnancy. // Obstet. Gynecol. Surv. 2000. V. 55. № 10. P. 633–643.
133.Pakarian F., Kaye J., Cason J. et al. Cancer associated human papillomaviruses: perinatal transmission and persistence. // Br. J. Obstet. Gynaecol. 1994. V. 101. № 6.P. 514–517.
134.Park H., Lee S.W., Lee I.H. et al. Rate of vertical transmission of human papillomavirus from mothers to infants: relationship between infection rate and mode of delivery.// Virol J. 2012. Apr V.12.№9.P.80.
135.Passmore J.A., Marais D.J., Sampson C. et al. Cervicovaginal, oral, and serum IgG and IgA responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasia. // J. Med. Virol. 2007. V. 79. № 9. P. 1375–1380.
136.Perino A., Giovannelli L., Schillaci R. et al. Human papillomavirus infection in couples undergoing in vitro fertilization procedures: impact on reproductive outcomes. // Fertil. Steril. 2011. V. 95. № 5. P. 1845–1848.
137.Pimenta J., Galindo C., Jenkins D. et al. Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination. // BMC Cancer. 2013. V. 13. P. 553.
138.Plummer M., Peto J, Franceschi S et al. Time since first sexual intercourse and the risk of cervical cancer.// Int J Cancer. 2012. V.130.№11.P.2638-2644.
139.Puranen M., Yliskoski M., Saarikoski S. et al.. Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. // Am. J. Obstet. Gynecol. 1996. V. 174. № 2. P. 694–699.
140.Puranen M.H. Yliskoski MH, Saarikoski SV et al. Exposure of an infant to cervical human papillomavirus infection of the mother is common. // Am. J. Obstet. Gynecol. 1997. V. 176. № 5. P. 1039–1045.
141.Raghupathy R., Kalinka J. Cytokine imbalance in pregnancy complications and its modulation.// Front Biosci. 2008.№13.P.985-994.
142.Rintala M.A., Grénman S.E., Pöllänen P.P. et al. Detection of high-risk HPV DNA in semen and its association with the quality of semen. // Int. J. STD AIDS. 2004. V. 15. № 11. P. 740–743.
142
143.Rintala M.A., Grénman S.E., Puranen M.H. et al. Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. // J. Clin. Microbiol. 2005. V. 43. № 1. P. 376–381.
144.Rintala M.A., Pöllänen P.P., Nikkanen V.P. Human papillomavirus DNA is found in the vas deferens. // J. Infect. Dis. 2002. V. 185. № 11. P. 1664–1667.
145.Rogovskaya S.I., Shabalova I.P., Mikheeva I.V. et al. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western Countries of the former Soviet Union, Caucasus Region and Central Asia. ICO Monograph Comprehensive control of human papillomavirus infections and related diseases in the central and Eastren Europe and Central Asia region Vaccine Vol. 31, Supp.7,2013.
146.Rombaldi R.L., Serafini E.P., Mandelli J. et al. Perinatal transmission of human papilomavirus DNA. // Virol. J. 2009. V. 6. P. 83.
147.Roperto S., Borzacchiello G., Esposito I. et al. Productive infection of bovine papillomavirus type 2 in the placenta of pregnant cows affected with urinary bladder tumors. // PLoS One. 2012. V. 7. № 3. e33569.
148.Roperto S., Comazzi S., Ciusani E. et al. PBMCs are additional sites of productive infection of bovine papillomavirus type 2. // J. Gen. Virol. 2011. V. 92. №
Pt 8. P. 1787–1794.
149.Roset Bahmanyar E., Paavonen J., Naud P. et al. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial. Gynecol Oncol. 2012 Dec.V.127.№3.P.440-450.
150.Rozmus-Warcholińska W., Loch T., Czuba B. et al. Genital warts associated with HPV infection during II and III trimester of pregnancy-a case report and analysis of treatment options Ginekol Pol. 2007.V.78.№11.P.888-891.
151.Russomano F., Reis A., de Camargo M.J. et al Efficacy in treatment of subclinical cervical HPV infections without intraepithelial neoplasia: systematic review. Sao Paulo Med. J. 2000; 118(4): 109-15.
152.Saini V., Arora S., Yadav A. Cytokines in recurrent pregnancy loss.//Clin Chim Acta. 2011. Apr 11.V.412(9-10).P.702-708.
143
153. Sarkola M.E., Grénman S.E., Rintala M.A. et al. Human papillomavirus in the placenta and umbilical cord blood. // Acta Obstet. Gynecol. Scand. 2008. V. 87. № 11.
P.1181–1188.
154.Saslow D., Solomon D., Lawson H.W. et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. // J. Low. Genit. Tract Dis. 2012. V. 16. № 3. P. 175–204.
155.Sedlacek T.V., Lindheim S., Eder C. et al. Mechanism for human papillomavirus transmission at birth. // Am. J. Obstet. Gynecol. 1989.V.161. № 1. P. 55–59.
156.Shi T.Y., Zhu M.L., He J. et al. Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women. // Hum. Genet. 2013. V. 132. № 3. P. 301–312.
157.Siebers A.G., Klinkhamer P.J., Grefte J.M. et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. // JAMA. 2009. V. 302. № 16. P. 1757–1764.
158.Silva C.S. da , Adad S.J., Hazarabedian de Souza M.A. et al. Increased frequency of bacterial vaginosis and Chlamydia trachomatis in pregnant women with human papillomavirus infection. // Gynecol. Obstet. Invest. 2004. V. 58. № 4. P. 189–193.
159.Silva M.A., Pontes N.E., Da Silva K.M. et al. Detection of bovine papillomavirus type 2 DNA in commercial frozen semen of bulls (Bos taurus). // Anim. Reprod. Sci. 2011. V. 129. № 3-4. P. 146–151.
160.Silverberg M.J. Thorsen P, Lindeberg H et al. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. // Obstet. Gynecol. 2003. V. 101. № 4. P. 645–52.
161.Skoczyński M., Goździcka-Józefiak A., Kwaśniewska A. Prevalence of human papillomavirus in spontaneously aborted products of conception. // Acta Obstet. Gynecol. Scand. 2011. V. 90. № 12. P. 1402–1405.
162.Smith E.M., Parker M.A., Rubenstein L.M. et al. Evidence for vertical transmission of HPV from mothers to infants. // Infect. Dis. Obstet. Gynecol. 2010. V. 2010. P. 326-369.
144
163.Smith E.M., Ritchie J.M., Yankowitz J. et al. Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission. // Sex. Transm. Dis. 2004. V. 31. № 1. P. 57–62.
164.Solomon D., Davey D., Kurman R. et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. // JAMA. 2002.V. 287. № 16.P. 2114–2119.
165.Spandorfer S., Bongiovanni A., Fasioulotis S. et al. Prevalence of cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome. Fertil Steril 2006.V. 86. № 3. P. 765–767.
166.Stanley M. Pathology and epidemiology of HPV infection in females. // Gynecol. Oncol. 2010. V. 117. № 2 Suppl. P. S5–10.
167.Stevens-Simon C., Nelligan D., Breese P. et al. The prevalence of genital human papillomavirus infections in abused and nonabused preadolescent girls. // Pediatrics. 2000. V. 106. № 4. P. 645–649.
168.Stillson T., Knight A.L., Elswick R.K. The effectiveness and safety of two cervical cytologic techniques during pregnancy. // J. Fam. Pract. 1997. V. 45. № 2.
P. 159–163.
169.Stonehocker J. Cervical cancer screening in pregnancy. // Obstet. Gynecol. Clin. North Am. 2013. V. 40. № 2. P. 269–82.
170.Syrjänen S. Current concepts on human papillomavirus infections in children. //
APMIS. 2010. V. 118. № 6-7. P. 494–509.
171. Syrjänen S., Puranen M. Human papillomavirus infections in children: the potential role of maternal transmission. // Crit. Rev. Oral Biol. Med. 2000. V. 11. № 2.
P. 259–274.
172. Tarka A., Szczepańska M., Raczyńska D. et al. Risk factors and frequency of occurrence of HPV DNA of high oncogenic types in paraepidermal epithelium cells of the uterine cervix, in the trophoblast, and in the peripheral blood of pregnant patients. Ginekol Pol 2008. №79. P.871–876.
173. Tenti P. Zappatore R, Migliora P et al. Perinatal transmission of human papillomavirus from gravidas with latent infections. // Obstet. Gynecol. 1999. V. 93.
№ 4. P. 475–479.
145
174.The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: developed and approved at the National Cancer Institute workshop in Bethesda, MD, December 12-13, 1988. // Diagn. Cytopathol. 1989. V. 5. № 3. P. 331–334.
175.Tjiong MY, van der Vange N, ten Kate FJ Tjiong M.Y. и др. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. // Gynecol. Oncol. 1999.V. 73. № 2. P. 285–291.
176.Tseng C.J., Liang CC, Soong YK, et al. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. // Obstet. Gynecol. 1998. V. 91. № 1. P. 92–96.
177.Ueda Y., Enomoto T., Miyatake T. et al. Postpartum outcome of cervical intraepithelial neoplasia in pregnant women determined by route of delivery. Reprod Sci 2009.V.16.№11.P.1034—1039.
178.Vernon S.D., Unger E.R., Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. // J. Clin. Microbiol. 2000. V. 38. № 2. P. 651–655.
179.Villiers E.M. de, Fauquet C., Broker T.R. et al. Classification of papillomaviruses. Virology 2004.V. 324.№1.P. 17–27.
180.Wang Y, Wang C, Qiao J et al. Relationship of cytopathology and cervical infection to outcome of in-vitro fertilization and embryo transfer. // Int. J. Gynaecol. Obstet. 2008. V. 101. № 1. P. 21–26.
181.Watts D.H., Koutsky L.A., Holmes K.K. et al. Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. // Am. J. Obstet. Gynecol. 1998. V. 178. № 2. P. 365–373.
182.Werness B.A., Levine A.J., Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. // Science. 1990.V.248. № 4951. P. 76–79.
183.Wheeler C.M., Hunt W.C., Schiffman M., et al. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J. Infect. Dis. 2006.
№194.P. 1291–1299.
146
184.WHO | Comprehensive cervical cancer control: A guide to essential practice [Электронный ресурс]. URL: http://www.who.int/cancer/publications/9241547006/en/ (дата обращения:19.04.2014).
185.WHO. Cervical cancer, human papillomavirus (HPV), and HPV vaccines. Key points for policy-makers and health professionals [Электронный ресурс].URL:http://whqlibdoc.who.int/hq/2008/WHO_RHR_08.14_eng.pdf?ua=1(дата обращения: 19.04.2014).
186.WHO. Human papillomavirus vaccines WHO position paper // Wkly. Epidemiol.
Rec. 2009.V. 84. № 15. P. 118–130.
187. Winckworth L.C., Nichol R. Question 2: do caesarean sections reduce the maternal-fetal transmission rate of human papillomavirus infection? Arch Dis Child. 2010.V.95.№1.P.70-73.
188.Winer R.L., Lee S.K., Hughes J.P. et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. // Am. J. Epidemiol. 2003. V. 157. № 3. P. 218–226.
189.Woodrow N., Permezel M, Butterfield L et al. Abnormal cervical cytology in pregnancy: experience of 811 cases. // Aust. N. Z. J. Obstet. Gynaecol. 1998. V. 38.
№ 2. P. 161–165.
190. Wu Y.M,, Wang T., He Y., et al. Clinical management of cervical intraepithelial neoplasia in pregnant and postpartum women. // Arch. Gynecol. Obstet. 2014.V. 289.
№ 5. P. 1071–1077.
191.Yang W., Song Y., Lu Y.L. et al. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in highrisk human papillomavirus-related cervical intraepithelial neoplasia. // Immunology. 2013. V. 139. № 4. P. 513–522.
192.You H. Liu Y, Agrawal N et al. Infection, replication, and cytopathology of
human papillomavirus type 31 in trophoblasts. // Virology. 2003.V. 316.
№ 2. P. 281–289.
147
193.Younes A.S., Csire M., Kapusinszky B. et al. Heterogeneous pathways of maternal-fetal transmission of human viruses (review). // Pathol. Oncol. Res. 2009. V.15. № 3.P.451–465.
194.Zenclussen A.C. Adaptive immune responses during pregnancy.//Am J Reprod Immunol. 2013.V.69.№4.P.291-303.
195.Zuo Z., Goel S., Carter J.E. Association of cervical cytology and HPV DNA status during pregnancy with placental abnormalities and preterm birth. // Am. J. Clin. Pathol. 2011. V. 136. № 2. P. 260–265.
196.zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. // Nat. Rev. Cancer. 2002. V. 2. № 5. P. 342–50.